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A simple, sensitive and rapid spectrophotometric method for the determination of tinidazole (TZ)
and metronidazole (MZ) in pure as well as in dosage form is described. The method is based on the
reduction of the nitro group of drugs using a novel and versatile reduction system comprising 10% PdC and formic acid. The resulting amine was then subjected to a condensation reaction with sodium
1,2-naphthaquinone-4-sulfonate (NQS) to form red Schiff base with an absorption maximum at 510 nm.
Beer’s law was obeyed in the concentration ranges 2.0 to 45.0 µg mL−1 and 1.5 to 37.0 µg mL−1 with
a limit of detection (LOD) of 0.44 µg mL−1 and 0.36µg mL−1 for TZ and MZ, respectively. Other
statistical analyses such as Student’s t test and F test values are included. The sensitivity of the method
surpasses that of the reported spectrophotometric methods. The method was successfully applied for
the assay of different tablets, suspensions and injections of TZ and MZ.
Key Words: Spectrophotometry, Tinidazole, Metronidazole, Pharmaceutical formulations.

Introduction
5-Nitroimidazoles such as tinidazole and metronidazole are extensively used as antiamoebic, antiprotozoal
and antibacterial drugs. The discovery of the antibacterial and antitrichomonal properties of the antibiotic
azomycin led to the investigation of nitroimidazoles as antiparasitic agents.1,2 The discovery of the antitrichomonal properties of metronidazole3,4 revolutionised the treatment of disease. Although the amoebicidal
properties of metronidazole were studied,3 it was not clinically tested until some years later. In laboratory
tests, metronidazole is effective against intestinal amoebiasis in rats and hepatic amoebiasis in hamsters and
is also active against E. histolytica in vitro.3,4The initial clinical tests of metronidazole indicated that it
was capable of curing invasive amoebic dysentery and amoebic liver abscess.5 Subsequent clinical tests have
established metronidazole as the drug of choice in the treatment of all forms of amoebiasis in humans.6,7
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Variation of the structure of metronidazole, principally to improve trichomonacidal activity and
metabolic stability, led to the discovery of tinidazole. Tinidazole is active against E. histolytica in vitro,cecal
amoebiasis in rats, and hepatic amoebiasis in hamsters.8 Clinical tests have established the value of tinidazole
in the treatment of intestinal and hepatic amoebiasis in humans.9 Tinidazole has about the same or slightly
greater efficacy than metronidazole in the treatment of trichomoniasis and in giardiasis, it has been found
to be effective against strains resistant to metronidazole.10
Tinidazole and metronidazole are officially determined by titrimetry, potentiometry and HPLC methods. Indian Pharmacopoeia11 (IP) describes the non-aqueous titration method using perchloric acid as titrant
and malachite green as indicator for the assay of tinidazole and metronidazole. British Pharmacopoeia12(BP)
describes potentiometric and non-aqueous titration methods using perchloric acid as titrant. United States
Pharmacopoeia13 (USP) describes HPLC and non-aqueous titration methods for the assay of metronidazole
only. Most of the spectrophotometric methods found in the literature for the determination of tinidazole and
metronidazole in the visible region involve initial reduction by treatment with Zn and HCl14−20 followed by
the diazotisation and coupling of the resulting amine. All these methods are less sensitive14−16,21, involve
tedious procedures such as heating and extraction,19,22,23 utilise costly reagents and involve an additional
diazotisation step24 . The present method is an attempt to overcome the shortcomings of the existing procedures and we succeeded in developing a simple, rapid and accurate spectrophotometric procedure for the
assay of tinidazole and metronidazole.

Experimental
Instrumentation and reagents
A JASCO model UVIDEC-610 UV-VIS spectrophotometer (Japan Spectroscopic Co. Ltd., Hachioji, Tokyo,
Japan) with 1.0 cm matched quartz cells was used for electronic spectral measurements.
Tinidazole and metronidazole were obtained as gift samples from Sarabhai Pharmaceuticals, Baroda,
India. Sodium hydroxide was purchased from BDH and sodium 1,2-naphthquinone-4-sulfonate was purchased
from Sigma, 10% Pd-C and formic acid used were purchased from E-Merck, Chennai, India. In addition
0.5 M sodium hydroxide and a freshly prepared 0.05% aqueous solution of sodium 1,2-naphthaquinone-4sulfonate were used. 90% formic acid was used for the reduction of the drugs. Distilled water was used for
the preparation of all aqueous solutions.

Reduction of the nitro group and preparation of standard drug solutions
First 25 mg of each drug was accurately weighed and placed in different 50 mL round bottomed flasks. Then
we added 5 mL of methanol and 0.25 g of 10% Pd-C. To the stirring suspension of this mixture was added
5 mL of 90% formic acid and the reaction (exothermic) was carried out at room temperature with constant
stirring for 30 min. After the completion of the hydrogenation, the mixture was filtered and washed with
methanol and diluted to 100 mL with water.
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General procedure
Preparation of calibration curves: Different volumes of the drug solutions (in the range 0.2 to 4.5 mL for
TZ and 0.15 to 3.7 mL for MZ) prepared above were accurately measured into different 25 mL volumetric
flasks. After the addition of 3.5 mL of 0.05% of NQS, 5 mL of 0.5 M sodium hydroxide was added and
diluted up to the mark with water. Absorbance of each solution was then measured after 15 min at 510 nm.
A calibration graph was constructed by plotting the absorbance against the concentration of the drug.
Assay procedure: An amount of bulk sample or tablet powder or a volume of injection or suspension
exactly equivalent to 25 mg of the drug was extracted with chloroform (3 x 5 mL portions). Combined
extracts were then evaporated on a steam bath and the residue was treated as for the preparation of the
standard drug solution. Then the procedure reported under ‘preparation of calibration curves’ was followed
for the assay of the drug content. The drug concentration was read from the appropriate calibration graph
prepared under identical conditions.

Results and Discussion
Reduction of the nitro group
Progress of the reaction of the reduction was continuously monitored by TLC using a CHCl3 , methanol
and acetic acid mixture in the ratio 93:5:2 as eluent, and Rf values were calculated. Rf values of tinidazole
and metronidazole were 0.85 and 0.9, respectively, and after reduction the Rf values were 0.63 and 0.67,
respectively.
Formic acid in the presence of 10% Pd-C is a rapid, versatile and selective reducing system for a wide
variety of nitro compounds.25 This system is readily available and easy to operate, and produces products
in good yield with high purity. The obvious advantages of the method over the other reduction procedures
are selective reduction of the nitro compounds in the presence of other reducible groups, rapid, high yield,
avoidance of strong acids, and the fact that the catalyst can be recovered and reused after washing with
water and ethanol without appreciable loss of activity.

Determination of absorption maximum
Reduced drugs when treated with NQS form a red product (Schiff base) in alkaline medium. To determine
absorption maximum, 10 µg mL−1 of each drug solution was reacted with NQS. After 15 min absorption
spectra were taken. The absorption spectrum of the product against reagent blank is shown in Figure 1.
510 nm is the maximum absorption wavelength for both solutions. Colourless reagent blank had practically
negligible absorbance at this wavelength.

Optimisation of the variables
To study the effect of the concentration of NQS and NaOH on the maximum absorbance, a number of
preliminary experiments were carried out. In a series of 25 mL volumetric flasks containing 50 µg mL−1
of the drug solution, keeping one reagent amount as constant, the concentration of the other reagent was
varied and the mixture was diluted up to the mark with water. After 15 min absorbance of each solution
was measured at 510 nm. It was found that a 0.05% solution of NQS in the range 3.0 to 4.0 mL and 0.5 M
NaOH in the range 4.5 to5.5 mL were necessary to achieve maximum colour intensity. Therefore, 3.5 mL of
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NQS and 5 mL of NaOH were recommended for all measurements. Results obtained for the optimisation of
the variables are presented graphically in Figure 2.
The effect of time on maximum absorbance was also tested by measuring the absorbance of both the
solutions at regular intervals and it was found that solutions show maximum absorbance after 15 min and
are stable for a further 24 h.
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Figure 1. Absorption maximum of TZ and MZ against blank.
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Figure 2. Effect of reagent concentration on absorbance.

Reaction sequence
Reduction of the nitro groups of both the drugs was carried out as explained in the experimental section.
When the resulting amine undergoes a condensation reaction in alkaline medium with NQS it forms a red
Schiff base with maximum absorbance at 510 nm. Although the reaction between the reduced drug and
NQS is instantaneous, for the development of maximum colour, the reaction mixture has to be kept for a
further 15 min. The probable reaction mechanism based on the reported method26 is given below.
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Optical characteristics and validation of the method
Optical characteristics such as Beer’s law limits, molar absorptivity and Sandell’s sensitivity, for both
tinidazole and metronidazole, are given in Table 1. Data of the regression analysis using the least squares
method made for the calibration curves are also given in the same table. The accuracy and precision of
the method were checked by analysing 6 replicate samples within the Beer’s law range containing the same
amount of each drug. Values of RSD were below 0.9%. The lower values of RSD indicate the good precision
and reproducibility of the method.
The validity of the proposed procedure for the determination of tinidazole and metronidazole in their
pure state was checked by analysing these drugs using the proposed method. The results obtained for pure
drugs were reproducible with low (0.81 and 0.33) relative standard deviations (RSD).
The limit of quantification (LOQ) was determined by taking the ratio of the standard deviation (σ)
of the blank with respect to water and the slope of the calibration curve multiplied by the factor 10. This
means that LOQ is approximately 3.3 times greater than LOD. LOD is well below the lower limit of the
Beer’s law range.

Interference studies
To study the potential interference problems from the commonly used excipients and other additives such
as glucose, dextrose, lactose, starch, sodium alginate, talc, magnesium alginate, magnesium stearate, and
ascorbic acid, recovery studies were carried out. Under the experimental conditions employed, to a known
amount of drug (metronidazole and tinidazole 10 µg mL−1 ), excipients in different concentrations were added
and analysed. Results of the recovery analysis are presented in Table 2. Excipients up to the concentrations
shown in the Table do not interfere with the assay. In addition recoveries in most cases were 100% and the
lower values of the RSD indicate the good precision of the method.
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Table 1. Optical characteristics and validation data.

Parameters
λ max (nm)
Beer’s law limit (µg mL−1 )
Molar absorptivity (L mol−1 cm−1 )
Sandell’s sensitivity (µg cm−2 )
Stability (h)
Regression equation (y)*
Slope, b
Intercept, a
Correlation coefficient, r
Recovery data ± RSD (%)**
Range of error, % ± (at 95% confidence limit)
Limit of detection (µg mL−1 )
Limit of quantification (µg mL−1 )

tinidazole
510
2 – 45
8.662 x 103
0.0285
24 hr

metronidazole
510
1.5 – 37
7.893 x 103
0.0216
24 hr

0.0312
0.002
0.9998
9.89 ± 0.81
0.89
0.44
1.35

0.0345
0.005
0.9999
10.24 ± 0.33
1.12
0.36
1.10

* Y = a + bx, where x is the concentration in µg mL−1
** Six replicate analysis of 10 µg mL−1 of the drugs.
Table 2. Determination of metronidazole and tinidazolea in the presence of excipients.

Excipients
Glucose
Starch
Lactose
Talc
Dextrose
Stearic acid
Sodium alginate
Magnesium alginate
Magnesium stearate
Ascorbic acid
a
b

Amount taken
(mg mL−1 )
48
55
40
27
53
36
29
32
35
42

% Recovery
Metronidazole
98.9 ± 0.82
101.2 ± 0.65
100.02 ± 0.48
98.9.5 ± 0.58
100.4 ± 0.67
99.3 ± 0.88
100.2 ± 0.75
101.04 ± 0.90
100.3 ± 0.85
100.6 ± 0.64

± % RSDb
Tinidazole
99.21 ± 0.56
98.38 ± 0.34
101.08 ± 0.54
99.12 ± 0.39
100.28 ± 0.43
100.23 ± 1.02
101.08 ± 0.65
100.84 ± 0.74
101.24 ± 1.04
99.64 ± 0.82

10 µg mL−1 of metronidazole and tinidazole were used.

Average of 6 replicate analyses.

Applicability of the method
The applicability of the proposed spectrophotometric procedure for the assay of tinidazole and metronidazole
was tested by analysing various available commercial formulations. The samples were also analysed using
the official method. The results (Table 3) of the analysis showed that the data are consistent with the label
claim of the formulations. The calibration curves showed a linear response over the range of concentrations
used in the assay procedures. The RSD values in the range 1.05 to 0.38 for the reproducibility and recovery
studies show that the method is precise and accurate. The precision and accuracy of the method was further
compared statistically using Student’s t test and variance ratio F test. At a 95% confidence level, the
calculated t-values and F-values do not exceed the tabulated values. Optical characteristics, precision and
accuracy data are presented in Table 3.
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Table 3. Analysis of tinidazole and metronidazole formulations.

Commercial
formulations
analysed
Tablets
Tinibaa
Fasagynb
Tina300c
Metrogyld
Flagyle
Aristogylf

Drug
content

Label
claim
in mg

Amount of drug found in mg*
Developed method
299.83 ±
499.02 ±
300.16 ±
399.02 ±
401.03 ±
200.23 ±

0.56
0.76
0.38
1.04
0.56
0.47

t
value

F
value

1.02
0.95
1.23
0.98
0.86
0.76

0.98
0.76
1.26
0.54
0.84
0.89

1.81
1.24
3.26
1.06
1.54
1.60

Official method (IP)
298.95 ±
498.12 ±
302.34 ±
398.10 ±
403.08 ±
198.44 ±

TZ
TZ
TZ
MZ
MZ
MZ

300
500
300
400
400
200

Injections
Metrogylg

MZ

500 mg
/100 mL

501.28 ± 1.05

502.18 ± 1.10

0.68

1.04

Metronh

MZ

500 mg
/100 mL

498.98 ± 0.73

498.04 ± 0.86

0.63

1.17

Suspension
Metrogyll

MZ

200 mg
/5 mL

200.76 ± 0.70

201.72 ± 1.18

0.93

1.69

*Average of 6 determinations ± RSD
t values (n = 5, at 95% confidence level tabulated value 2.57)
F values (n1 and n2 = 5, at 95% confidence level tabulated value 5.05)
Marketed by Zydus Cadilaa , Pfizerb , Bombay tabletsc , Uniqued,g,I , Rhone-Poulence , Aristof , Alkemh

In addition it is observed that there is no interference from the excipients used in the formulations.
Hence, this method can be adopted for the routine quality control of tinidazole and metronidazole in bulk
as well as in formulations.

Conclusion
Reported spectrophotometric methods for the assay of these drugs are based on the initial reduction of the
nitro group of drugs using the Zn-HCl reduction system and it was observed that all those methods suffer
from low sensitivity and that some methods involve additional tedious procedures such as diazotisation,
heating or extraction. A comparison of the present method with the reported methods is given in Table
4. The novel reduction system proposed in this method comprises 10% Pd-C and formic acid and gives a
direct condensation reaction with NQS to form red Schiff base. In addition the advantages of this reduction
mixture are highlighted in the experimental section. Interestingly, the sensitivity of the method surpasses
that of the reported methods within a wide range of detection limits. The proposed spectrophotometric
method is simple, sensitive, accurate and rapid.
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Table 4. Literature survey of the spectrophotometric determination of tinidazole and metronidazole.

Reagents used

λmax in
nm

p-Dimethyl amino
cinnam aldehyde

510

4-Dimethyl amino
benzaldehyde

Beer’s law
range in µg
mL-1
50 – 400 for
MZ

Critical experimental conditions involved

Refer
ence

Involves reduction with Zn-HCl and low
sensitivity. Analysed only MZ.

14

550

10 – 100 for
TZ

Involves reduction with Zn-HCl and low
sensitivity. Analysed only TZ.

15

β-Naphthol

480

10 – 80 for MZ

Involves reduction with Zn-HCl and
diazotisation and coupling with the cited
reagent. Low sensitivity. Analysed only MZ.

16

Metol and K2Cr2O7

720

2.4 – 24 for TZ
1.6 – 16 for
MZ

Involves reduction with Zn-HCl and the use
of buffer of pH 2.9 and colour formation, and
its stability is pH dependent.

17

NN-dimethyl-pphenylenediamine and
chloramine-T

540

4 – 36 for TZ
3 – 24 for MZ

Involves reduction with Zn-HCl and the use
of buffer of pH 7 and colour formation and
its stability is pH dependent.

18

Vanillin

412

10 – 50 for TZ

Involves reduction with Zn-HCl and heating
for20 min with the reagent and cooling before
absorbance measurement. Analysed only TZ.

19

Salicylaldehyde

380

20 – 70 for TZ

Involves reduction with Zn-HCl and low
sensitivity. Analysed only TZ.

20

Bromocresol purple

618

2 – 24 for MZ

21
-do-

Bromocresol green

654

2 – 22 for MZ

Involves extraction with CHCl3 and use of
buffer of pH 10.
Involves extraction with CHCl3 and use of
buffer of pH 9.5.

NaOH and KCl

368

10 – 30 for TZ

Low sensitivity and involves heating at 100 oC
for 10 min.

22

Bromothymol blue

440

not given

Involves extraction with CHCl3 and use of
buffer of pH 4.4.

23

Methylbenzothiazolin-2onehydrazine (MBTH)

500 and
490

1-32 for MZ
4-36 for TZ

Involves reduction with Zn-HCl and MBTH
is a costly reagent.

24

N(1-naphthyl) ethylene
diamine dihydrochloride
(NEDA)

520 and
505

0.5 – 18 for
MZ and TZ

Involves reduction with Zn-HCl and an
additional step of diazotisation. Beer’s law
valid for low range of concentration.

24
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